Protocol Control
- Name: Sample Derivation 6
- Version: v4.6
- Effective date: 2025-07-11T00:00:00.000Z
- Signed by: Dr. Alice Morgan
- Studies using protocol: 7
- Experiments using protocol: 7
Protocol PTC-0139
Hide
Versioned procedural standard with sign-off evidence and execution coverage across studies. Business and scientific purpose: improve experimental quality, reproducibility, and cycle time from design to validated evidence. Protocol PTC-0139 is connected to linked entities, metrics, and workflow actions in this workspace. Use these panels to review evidence, identify risks, and decide the next best scientific action. The view uses deterministic demo data shaped to mirror realistic drug discovery operations.
Execution Health
- Linked assay runs: 17
- Runs requiring review: 4
- Compliance status: Healthy
- Last evidence refresh: 2025-08-13T00:00:00.000Z
Experiments Under Protocol
| id | studyId | owner | status | startedAt |
|---|---|---|---|---|
| EX-0008 | ST-056 | Eve Patel | paused | 2025-08-13T00:00:00.000Z |
| EX-0219 | ST-060 | Cara Singh | completed | 2025-06-06T00:00:00.000Z |
| EX-0252 | ST-021 | Dr. Alice Morgan | active | 2025-12-27T00:00:00.000Z |
| EX-0348 | ST-045 | Daniel Osei | active | 2025-11-24T00:00:00.000Z |
| EX-0427 | ST-059 | Dr. Alice Morgan | completed | 2025-11-23T00:00:00.000Z |
| EX-0512 | ST-002 | Dr. Alice Morgan | paused | 2025-12-05T00:00:00.000Z |
| EX-0561 | ST-001 | Daniel Osei | planned | 2025-05-01T00:00:00.000Z |